Trial Profile
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Feb 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 27 Feb 2016 New trial record